Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes
Condition: Diabetes Mellitus, Type 2 Interventions: Drug: AZD9567; Drug: Prednisolone; Other: Placebo Sponsors: AstraZeneca; Parexel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Diabetes | Diabetes Type 2 | Endocrinology | Prednisolone | Research | Study